Posted On: 09/08/2013 2:15:14 PM
Post# of 250679
Sorrento Therapeutics, Inc. SRNE Company Overview
Stock Message Board http://investorshangout.com/search?q=SRNE&...mp;yt1=Go!
Sorrento Therapeutics, Inc. SRNE Current Price and Quotes
Last Price 9.25
Previous Close 9.48 Open 9.48
Daily Range 9.48 - 9.25 52wk Range 22.50 - 1.50
Volume 1,059 Dividend N/A
Average Vol (3m) 1,554 Yield N/A
Sorrento Therapeutics, Inc. SRNE
Company Information
6042 Cornerstone Ct. West
Suite B
San Diego, CA 92121
Website: http://www.sorrentotherapeutics.com
Phone: 858-210-3700
Email: info@sorrentotherapeutics.com
Sorrento Therapeutics, Inc. SRNE
Sorrento Therapeutics, Inc. (STI) provides access to its novel and proprietary technology platform for the construction of fully human antibody libraries, the STI Technology.
The STI Technology applies RNA transcription for the amplification of human immunoglobin variable domain sequences.
Sorrento Therapeutics, Inc. SRNE
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000850261
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Business Status Development Stage Company a/o Dec 31, 2007
Incorporated In: DE, USA
Year of Inc. 1989
Employees Not Available
Company Officers/Contacts
Henry Ji President, CEO
Richard G. Vincent CFO
Company Directors
Jane Hsiao
Kim D. Janda
Scott Salka
Diane D-S Tang-Liu
Company Notes
Formerly=QuikByte Software, Inc. until 12-2009
Last Known Address (3-00): 2213 Rockefeller, Suite 2, Redondo Beach, CA 90278
Service Providers
Auditor/Accountant
Mayer Hoffman McCann P.C.
11440 Tomahawk Creek Parkway
Leawood, KS, 66211
United States
Legal Counsel
Not Available
Investor Relations Firm
Micromedia Strategies Inc.
7710 Hazard Center Drive
San Diego, CA, 92108
United States
Sorrento Therapeutics, Inc. SRNE
SRNE Security Details
Share Structure
Market Value1 $124,347,916 a/o Sep 06, 2013
Shares Outstanding 13,443,018 a/o Aug 01, 2013
Float Not Available
Authorized Shares Not Available
Par Value Not Available
Shareholders
Shareholders of Record 202 a/o Mar 25, 2013
Security Notes
Capital Change=shs decreased by 1 for 20 split Pay date=03/16/2007.
Capital Change=shs decreased by 1 for 10 split Pay date=10/07/2008.
Capital Change=shs decreased by 1 for 25 split. Ex-date=08/01/2013.
Short Selling Data
Short Interest 0 (-100%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Executive Registrar & Transfer Agent, Inc.
Sorrento Therapeutics, Inc. SRNE Recent News
Sept 6, 2013 Sorrento Therapeutics to Present at Two Healthcare Conferences
Aug 16, 2013 PENNYGOVERNANCE Daily Stock Watch Sorrento Therapeutics, Inc. (OTCQB:SRNE), Crown Equity Holdings, Inc. (OTCQB:CRWE), and Nomura Holdings, Inc. (NYSE:NMR)
Aug 5, 2013 Sorrento Therapeutics and IGDRASOL Proceed with Development of Cynviloq(TM) under 505(b)(2) Bioequivalence Regulatory Pathway
Aug 1, 2013 Sorrento Therapeutics Announces Reverse Split of Common Stock
Jul 9, 2013 Sorrento Therapeutics and Ben-Gurion University Sign an Agreement for the Development of Anti-Hepatitis C Virus Antibodies
Jul 1, 2013 Sorrento Therapeutics, Inc. and IGDRASOL Will Present Preliminary Phase III Data Analysis for Cynviloq at the 4th International Nanomedicine Conference in Sydney, Australia
Jun 24, 2013 Sorrento Therapeutics Presents Preclinical Data of its Fully Human Antibody Programs Targeting Anti-PD-L1 and Anti-PD-1 at the 8th Annual Next Generation Protein Therapeutics Summit
Jun 21, 2013 Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Basel, Switzerland
Sorrento Therapeutics, Inc. SRNE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 584 529 683 -
Cost of Revenue - - - -
Gross Profit 584 529 683 -
Operating Expenses
Research and Development 3,830 2,570 1,392 410
Sales, General and Admin. 1,606 1,201 1,102 544
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,853) (3,242) (1,812) (954)
Income From Continuing Operations
Add'l Income/Expense Items 7 6 4 12
Earnings Before Interest and Tax (4,845) (3,236) (1,808) (942)
Interest Expense - - - -
Earnings Before Tax (4,845) (3,236) (1,808) (942)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,845) (3,236) (1,808) (942)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,845) (3,236) (1,808) (942)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,845) (3,236) (1,808) (942)
SRNE Sorrento Therapeutics, Inc. Research DD Guide
SRNE Sorrento Therapeutics, Inc. Stock Message Board http://investorshangout.com/search?q=SRNE&...mp;yt0=Go!
SRNE Sorrento Therapeutics, Inc. Stock Quote http://www.otcmarkets.com/stock/SRNE/quote
SRNE Sorrento Therapeutics, Inc. Stock Chart http://www.otcmarkets.com/stock/SRNE/chart
SRNE Sorrento Therapeutics, Inc. Company Info http://www.otcmarkets.com/stock/SRNE/company-info
SRNE Sorrento Therapeutics, Inc. Recent News http://www.otcmarkets.com/stock/SRNE/news
SRNE Sorrento Therapeutics, Inc. Financials http://www.otcmarkets.com/stock/SRNE/financials
SRNE Sorrento Therapeutics, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/SRNE/filings
SRNE Sorrento Therapeutics, Inc. Short Sales http://www.otcmarkets.com/stock/SRNE/short-sales
SRNE Sorrento Therapeutics, Inc. Insider Disclosure http://www.otcmarkets.com/stock/SRNE/insider-transactions
SRNE Sorrento Therapeutics, Inc. Research Reports http://www.otcmarkets.com/stock/SRNE/research
SRNE Sorrento Therapeutics, Inc. Summary http://finance.yahoo.com/q?s=SRNE
SRNE Sorrento Therapeutics, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=SRNE+Historical+Prices
SRNE Sorrento Therapeutics, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=SRNE
SRNE Sorrento Therapeutics, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=SRNE+Basic+Chart
SRNE Sorrento Therapeutics, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SRNE+Basic+Tech.+Analysis
SRNE Sorrento Therapeutics, Inc. Headlines http://finance.yahoo.com/q/h?s=SRNE+Headlines
SRNE Sorrento Therapeutics, Inc. Press Releases http://finance.yahoo.com/q/p?s=SRNE+Press+Releases
SRNE Sorrento Therapeutics, Inc. Company Profile http://finance.yahoo.com/q/pr?s=SRNE+Profile
SRNE Sorrento Therapeutics, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=SRNE+Key+Statistics
SRNE Sorrento Therapeutics, Inc. Industry http://finance.yahoo.com/q/in?s=SRNE+Industry
SRNE Sorrento Therapeutics, Inc. Major Holders http://finance.yahoo.com/q/mh?s=SRNE+Major+Holders
SRNE Sorrento Therapeutics, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=SRNE+Insider+Transactions
SRNE Sorrento Therapeutics, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=SRNE+Insider+Roster
SRNE Sorrento Therapeutics, Inc. Income Statement http://finance.yahoo.com/q/is?s=SRNE
SRNE Sorrento Therapeutics, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=SRNE
SRNE Sorrento Therapeutics, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=SRNE+Cash+Flow&annual
SRNE Sorrento Therapeutics, Inc. Nasdaq http://www.nasdaq.com/symbol/SRNE
SRNE Sorrento Therapeutics, Inc. Market Watch http://www.marketwatch.com/investing/stock/SRNE
SRNE Sorrento Therapeutics, Inc. Bloomberg http://www.bloomberg.com/quote/SRNE:US
SRNE Sorrento Therapeutics, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=SRNE
SRNE Sorrento Therapeutics, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=SRNE
SRNE Sorrento Therapeutics, Inc. Barchart http://www.barchart.com/quotes/stocks/SRNE
SRNE Sorrento Therapeutics, Inc. OTC Short Report http://otcshortreport.com/index.php?index=SRNE
SRNE Sorrento Therapeutics, Inc. Investopedia http://www.investopedia.com/markets/stocks/SRNE/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Stock Message Board http://investorshangout.com/search?q=SRNE&...mp;yt1=Go!
Sorrento Therapeutics, Inc. SRNE Current Price and Quotes
Last Price 9.25
Previous Close 9.48 Open 9.48
Daily Range 9.48 - 9.25 52wk Range 22.50 - 1.50
Volume 1,059 Dividend N/A
Average Vol (3m) 1,554 Yield N/A
Sorrento Therapeutics, Inc. SRNE
Company Information
6042 Cornerstone Ct. West
Suite B
San Diego, CA 92121
Website: http://www.sorrentotherapeutics.com
Phone: 858-210-3700
Email: info@sorrentotherapeutics.com
Sorrento Therapeutics, Inc. SRNE
Sorrento Therapeutics, Inc. (STI) provides access to its novel and proprietary technology platform for the construction of fully human antibody libraries, the STI Technology.
The STI Technology applies RNA transcription for the amplification of human immunoglobin variable domain sequences.
Sorrento Therapeutics, Inc. SRNE
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000850261
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Business Status Development Stage Company a/o Dec 31, 2007
Incorporated In: DE, USA
Year of Inc. 1989
Employees Not Available
Company Officers/Contacts
Henry Ji President, CEO
Richard G. Vincent CFO
Company Directors
Jane Hsiao
Kim D. Janda
Scott Salka
Diane D-S Tang-Liu
Company Notes
Formerly=QuikByte Software, Inc. until 12-2009
Last Known Address (3-00): 2213 Rockefeller, Suite 2, Redondo Beach, CA 90278
Service Providers
Auditor/Accountant
Mayer Hoffman McCann P.C.
11440 Tomahawk Creek Parkway
Leawood, KS, 66211
United States
Legal Counsel
Not Available
Investor Relations Firm
Micromedia Strategies Inc.
7710 Hazard Center Drive
San Diego, CA, 92108
United States
Sorrento Therapeutics, Inc. SRNE
SRNE Security Details
Share Structure
Market Value1 $124,347,916 a/o Sep 06, 2013
Shares Outstanding 13,443,018 a/o Aug 01, 2013
Float Not Available
Authorized Shares Not Available
Par Value Not Available
Shareholders
Shareholders of Record 202 a/o Mar 25, 2013
Security Notes
Capital Change=shs decreased by 1 for 20 split Pay date=03/16/2007.
Capital Change=shs decreased by 1 for 10 split Pay date=10/07/2008.
Capital Change=shs decreased by 1 for 25 split. Ex-date=08/01/2013.
Short Selling Data
Short Interest 0 (-100%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Executive Registrar & Transfer Agent, Inc.
Sorrento Therapeutics, Inc. SRNE Recent News
Sept 6, 2013 Sorrento Therapeutics to Present at Two Healthcare Conferences
Aug 16, 2013 PENNYGOVERNANCE Daily Stock Watch Sorrento Therapeutics, Inc. (OTCQB:SRNE), Crown Equity Holdings, Inc. (OTCQB:CRWE), and Nomura Holdings, Inc. (NYSE:NMR)
Aug 5, 2013 Sorrento Therapeutics and IGDRASOL Proceed with Development of Cynviloq(TM) under 505(b)(2) Bioequivalence Regulatory Pathway
Aug 1, 2013 Sorrento Therapeutics Announces Reverse Split of Common Stock
Jul 9, 2013 Sorrento Therapeutics and Ben-Gurion University Sign an Agreement for the Development of Anti-Hepatitis C Virus Antibodies
Jul 1, 2013 Sorrento Therapeutics, Inc. and IGDRASOL Will Present Preliminary Phase III Data Analysis for Cynviloq at the 4th International Nanomedicine Conference in Sydney, Australia
Jun 24, 2013 Sorrento Therapeutics Presents Preclinical Data of its Fully Human Antibody Programs Targeting Anti-PD-L1 and Anti-PD-1 at the 8th Annual Next Generation Protein Therapeutics Summit
Jun 21, 2013 Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Basel, Switzerland
Sorrento Therapeutics, Inc. SRNE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 584 529 683 -
Cost of Revenue - - - -
Gross Profit 584 529 683 -
Operating Expenses
Research and Development 3,830 2,570 1,392 410
Sales, General and Admin. 1,606 1,201 1,102 544
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,853) (3,242) (1,812) (954)
Income From Continuing Operations
Add'l Income/Expense Items 7 6 4 12
Earnings Before Interest and Tax (4,845) (3,236) (1,808) (942)
Interest Expense - - - -
Earnings Before Tax (4,845) (3,236) (1,808) (942)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,845) (3,236) (1,808) (942)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,845) (3,236) (1,808) (942)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,845) (3,236) (1,808) (942)
SRNE Sorrento Therapeutics, Inc. Research DD Guide
SRNE Sorrento Therapeutics, Inc. Stock Message Board http://investorshangout.com/search?q=SRNE&...mp;yt0=Go!
SRNE Sorrento Therapeutics, Inc. Stock Quote http://www.otcmarkets.com/stock/SRNE/quote
SRNE Sorrento Therapeutics, Inc. Stock Chart http://www.otcmarkets.com/stock/SRNE/chart
SRNE Sorrento Therapeutics, Inc. Company Info http://www.otcmarkets.com/stock/SRNE/company-info
SRNE Sorrento Therapeutics, Inc. Recent News http://www.otcmarkets.com/stock/SRNE/news
SRNE Sorrento Therapeutics, Inc. Financials http://www.otcmarkets.com/stock/SRNE/financials
SRNE Sorrento Therapeutics, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/SRNE/filings
SRNE Sorrento Therapeutics, Inc. Short Sales http://www.otcmarkets.com/stock/SRNE/short-sales
SRNE Sorrento Therapeutics, Inc. Insider Disclosure http://www.otcmarkets.com/stock/SRNE/insider-transactions
SRNE Sorrento Therapeutics, Inc. Research Reports http://www.otcmarkets.com/stock/SRNE/research
SRNE Sorrento Therapeutics, Inc. Summary http://finance.yahoo.com/q?s=SRNE
SRNE Sorrento Therapeutics, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=SRNE+Historical+Prices
SRNE Sorrento Therapeutics, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=SRNE
SRNE Sorrento Therapeutics, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=SRNE+Basic+Chart
SRNE Sorrento Therapeutics, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SRNE+Basic+Tech.+Analysis
SRNE Sorrento Therapeutics, Inc. Headlines http://finance.yahoo.com/q/h?s=SRNE+Headlines
SRNE Sorrento Therapeutics, Inc. Press Releases http://finance.yahoo.com/q/p?s=SRNE+Press+Releases
SRNE Sorrento Therapeutics, Inc. Company Profile http://finance.yahoo.com/q/pr?s=SRNE+Profile
SRNE Sorrento Therapeutics, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=SRNE+Key+Statistics
SRNE Sorrento Therapeutics, Inc. Industry http://finance.yahoo.com/q/in?s=SRNE+Industry
SRNE Sorrento Therapeutics, Inc. Major Holders http://finance.yahoo.com/q/mh?s=SRNE+Major+Holders
SRNE Sorrento Therapeutics, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=SRNE+Insider+Transactions
SRNE Sorrento Therapeutics, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=SRNE+Insider+Roster
SRNE Sorrento Therapeutics, Inc. Income Statement http://finance.yahoo.com/q/is?s=SRNE
SRNE Sorrento Therapeutics, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=SRNE
SRNE Sorrento Therapeutics, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=SRNE+Cash+Flow&annual
SRNE Sorrento Therapeutics, Inc. Nasdaq http://www.nasdaq.com/symbol/SRNE
SRNE Sorrento Therapeutics, Inc. Market Watch http://www.marketwatch.com/investing/stock/SRNE
SRNE Sorrento Therapeutics, Inc. Bloomberg http://www.bloomberg.com/quote/SRNE:US
SRNE Sorrento Therapeutics, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=SRNE
SRNE Sorrento Therapeutics, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=SRNE
SRNE Sorrento Therapeutics, Inc. Barchart http://www.barchart.com/quotes/stocks/SRNE
SRNE Sorrento Therapeutics, Inc. OTC Short Report http://otcshortreport.com/index.php?index=SRNE
SRNE Sorrento Therapeutics, Inc. Investopedia http://www.investopedia.com/markets/stocks/SRNE/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
(0)
(0)
